About RestoreFlow Allografts
RestoreFlow Allografts is a company based in Fox River Grove (United States) founded in 2013 was acquired by LeMaitre Vascular in November 2016.. RestoreFlow Allografts has raised $750 thousand across 1 funding round from investors including LeMaitre Vascular. RestoreFlow Allografts operates in a competitive market with competitors including MiMedx Group, Satellite Bio, KaloCyte, Stratatech Corp and CorNeat Vision, among others.
- Headquarter Fox River Grove, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$750 K (USD)
in 1 rounds
-
Latest Funding Round
$750 K (USD), Seed
Jun 13, 2013
- Investors
-
Employee Count
Employee Count
-
Acquired by
LeMaitre Vascular
(Nov 10, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of RestoreFlow Allografts
RestoreFlow Allografts has successfully raised a total of $750K through 1 strategic funding round. The most recent funding activity was a Seed round of $750 thousand completed in June 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $750,000
-
First Round
First Round
(13 Jun 2013)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2013 | Amount | Seed - RestoreFlow Allografts | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in RestoreFlow Allografts
RestoreFlow Allografts has secured backing from 1 investor. Prominent investors backing the company include LeMaitre Vascular. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Devices for peripheral vascular disease treatment are developed and marketed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by RestoreFlow Allografts
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - RestoreFlow Allografts
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Restoreflow Allografts Comparisons
Competitors of RestoreFlow Allografts
RestoreFlow Allografts operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MiMedx Group, Satellite Bio, KaloCyte, Stratatech Corp and CorNeat Vision, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
|
|
| domain | founded_year | HQ Location |
Proprietary implantable satellite organs are developed for cell therapy.
|
|
| domain | founded_year | HQ Location |
Nanotechnology-based red blood cell substitutes are developed.
|
|
| domain | founded_year | HQ Location |
Cell-based skin substitutes are developed for therapeutic and research uses.
|
|
| domain | founded_year | HQ Location |
Nanotechnology-based artificial corneal implants are developed for ophthalmic use.
|
|
| domain | founded_year | HQ Location |
Developer of surgical mesh for wound management
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about RestoreFlow Allografts
When was RestoreFlow Allografts founded?
RestoreFlow Allografts was founded in 2013.
Where is RestoreFlow Allografts located?
RestoreFlow Allografts is headquartered in Fox River Grove, United States. It is registered at Fox River Grove, Illinois, United States.
Who is the current CEO of RestoreFlow Allografts?
Torico D Jones is the current CEO of RestoreFlow Allografts.
Is RestoreFlow Allografts a funded company?
RestoreFlow Allografts is a funded company, having raised a total of $750K across 1 funding round to date. The company's 1st funding round was a Seed of $750K, raised on Jun 13, 2013.
What does RestoreFlow Allografts do?
RestoreFlow Allografts was established in 2013 in Fox River Grove, United States. Human tissue-based regenerative medicines are developed by the company to treat various diseases within the biotechnology sector. Operations center on research and production of these therapies. Leadership is held by CEO Torico D Jones, with activities conducted primarily in the U.S. market.
Who are the top competitors of RestoreFlow Allografts?
RestoreFlow Allografts's top competitors include MiMedx Group, KaloCyte and Satellite Bio.
Who are RestoreFlow Allografts's investors?
RestoreFlow Allografts has 1 investor. Key investors include LeMaitre Vascular.